Plasma N -Glycans as Emerging Biomarkers of Cardiometabolic Risk: A Prospective Investigation in the EPIC-Potsdam Cohort...
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024
Project: IMforFUTURE
Updated at: 28-04-2024